» Articles » PMID: 30528987

Predicted Heart Mass is the Optimal Metric for Size Match in Heart Transplantation

Abstract

Background: Donor-recipient size match is traditionally assessed by body weight. We assessed the ability of 5 size match metrics-predicted heart mass (PHM), weight, height, body mass index (BMI) and body surface area (BSA)-to predict 1-year mortality after heart transplant and to assess the effect of size match on donor heart turn down for size.

Methods: The study cohort comprised 19,168 adult heart transplant recipients in the United Network for Organ Sharing registry between 2007 and 2016. Each size match metric was divided into 7 equally sized groups using the donor-recipient ratio for each metric. Single and multivariable Cox proportional hazard models for mortality 1 year after transplant were constructed.

Results: Recipients in the severely (donor-recipient PHM ratio 0.54-0.86) undersized group for PHM experienced increased mortality, with a hazard ratio of 1.34 (95% confidence interval, 1.13-1.59; p < 0.001). There was no increased risk of death at 1 year if donors were undersized for weight, height, BMI, or BSA. We found that 32% of heart offers turned down for donor size would be acceptable using a PHM threshold of 0.86 or greater and that 14% of offers accepted (most of which are female donor to male recipient) were below this threshold.

Conclusions: PHM is the optimal donor-recipient size match metric for prediction of mortality after heart transplant. Many offers turned down for donor size were above the threshold for adequacy of size match by PHM identified, and thus, the use of PHM could improve donor heart utilization and post-transplant survival.

Citing Articles

The Korean Organ Transplant Registry (KOTRY): Third Official Adult Heart Transplant Report.

Choi H, Lee S, Hyun J, Kim D, Choi D, Jeon E Korean Circ J. 2024; 55(2):79-96.

PMID: 39434361 PMC: 11875971. DOI: 10.4070/kcj.2024.0176.


Impact of Donor-Recipient BMI Ratio on Survival Outcomes of Heart Transplant Recipients: A Retrospective Analysis Study.

Zhong Y, Zhang C, Wang Y, Liu M, Shang X, Dong N Clin Cardiol. 2024; 47(9):e70010.

PMID: 39233528 PMC: 11375284. DOI: 10.1002/clc.70010.


Combined Organ Transplantation in Patients with Advanced Liver Disease.

Zhang I, Lurje I, Lurje G, Knosalla C, Schoenrath F, Tacke F Semin Liver Dis. 2024; 44(3):369-382.

PMID: 39053507 PMC: 11449526. DOI: 10.1055/s-0044-1788674.


Deep Learning for Automated Measurement of Total Cardiac Volume for Heart Transplantation Size Matching.

Szugye N, Mahalingam N, Somasundaram E, Villa C, Segala J, Segala M Pediatr Cardiol. 2024; 46(3):590-598.

PMID: 38570368 PMC: 11842492. DOI: 10.1007/s00246-024-03470-4.


One Year Outcomes Following Transplantation with COVID-19-Positive Donor Hearts: A National Database Cohort Study.

Wolfe S, Singh R, Paneitz D, Rabi S, Chukwudi C, Asija R J Cardiovasc Dev Dis. 2024; 11(2).

PMID: 38392260 PMC: 10889800. DOI: 10.3390/jcdd11020046.